Variant report
Variant | nsv611667 |
---|---|
Chromosome Location | chr8:86517085-86528117 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:86525634..86527923-chr8:86533854..86535632,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117769196 | chr8:86521810-86521811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535210637 | chr8:86521825-86521826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73688531 | chr8:86521841-86521842 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs554400077 | chr8:86521846-86521847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575747123 | chr8:86521874-86521875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534361047 | chr8:86521880-86521881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554032977 | chr8:86521882-86521883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577501740 | chr8:86521967-86521968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543084956 | chr8:86521989-86521990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562962491 | chr8:86522038-86522039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576448376 | chr8:86522055-86522056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189470172 | chr8:86522072-86522073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562019097 | chr8:86522081-86522082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112257741 | chr8:86522082-86522083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527684791 | chr8:86522094-86522095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547854324 | chr8:86522121-86522122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564381682 | chr8:86522122-86522123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533095135 | chr8:86522141-86522142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549912083 | chr8:86522169-86522170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180742988 | chr8:86522171-86522172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548351386 | chr8:86523645-86523646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59542630 | chr8:86523742-86523743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79861909 | chr8:86523773-86523774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182144131 | chr8:86523793-86523794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551192104 | chr8:86523838-86523839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571370296 | chr8:86523853-86523854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376182576 | chr8:86523883-86523884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550588917 | chr8:86523903-86523904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143393310 | chr8:86523924-86523925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146687023 | chr8:86523998-86523999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372024079 | chr8:86524041-86524042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555955059 | chr8:86524102-86524103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375264748 | chr8:86524127-86524128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76457006 | chr8:86524131-86524132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535281528 | chr8:86524161-86524162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111239797 | chr8:86524189-86524190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs67745000 | chr8:86524190-86524191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs398047335 | chr8:86524198-86524199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557959858 | chr8:86524253-86524254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs578073643 | chr8:86524261-86524262 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539973409 | chr8:86524274-86524275 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186732778 | chr8:86524284-86524285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34899261 | chr8:86524344-86524345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140277064 | chr8:86524446-86524447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561700036 | chr8:86524464-86524465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573565174 | chr8:86524501-86524502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542524356 | chr8:86524503-86524504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117150418 | chr8:86524504-86524505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116697103 | chr8:86524570-86524571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113119328 | chr8:86524588-86524589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:86521800-86522200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:86523600-86524600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr8:86523800-86524000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr8:86524000-86526000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
5 | chr8:86524000-86528200 | Enhancers | Adipose Nuclei | Adipose |
6 | chr8:86524600-86525400 | Enhancers | Right Atrium | heart |
7 | chr8:86524600-86526000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
8 | chr8:86525000-86525200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr8:86525400-86526600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr8:86526000-86526800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr8:86526000-86527200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr8:86526000-86527200 | Enhancers | Liver | Liver |
13 | chr8:86526000-86527400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr8:86526000-86527800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr8:86526400-86527000 | Enhancers | Brain Hippocampus Middle | brain |
16 | chr8:86526400-86527800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr8:86526400-86528000 | Enhancers | Brain Anterior Caudate | brain |
18 | chr8:86526400-86528000 | Enhancers | Brain Substantia Nigra | brain |
19 | chr8:86526600-86527200 | Enhancers | HMEC | breast |
20 | chr8:86526600-86527400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr8:86526800-86527200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr8:86527000-86528400 | Weak transcription | Brain Hippocampus Middle | brain |